Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease

• Published in: Neuroscience Vol. 62; no. 1; pp. 1 - 13
• Main Authors: Vickers, J.C., Riederer, B.M., Marugg, R.A., Buée-Scherrer, V., Buée, L., Delacourte, A., Morrison, J.H.
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Ltd 01.09.1994; Elsevier
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Aging - metabolism; Alzheimer Disease - metabolism; Biological and medical sciences; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Female; Hippocampus - metabolism; Hippocampus - pathology; Humans; Immunoblotting; Immunohistochemistry; Male; Medical sciences; Middle Aged; Neurofilament Proteins - metabolism; Neurology; Neurons - metabolism; Reference Values; Thiazoles; PBS; SDS-PAGE; FITC; AD; NF-L; NF-H; NF; NF-M; MAP; NFT; Human; Proteins; Nervous system diseases; Neurofilament; Senescence; Alzheimer disease; Cytoskeleton; Degenerative disease; Hippocampus
• ISSN: 0306-4522; 1873-7544
• DOI: 10.1016/0306-4522(94)90310-7

The distribution of immunoreactivity for the neurofilament triplet class of intermediate filament proteins was examined in the hippocampus of young, adult and elderly control cases and compared to that of Alzheimer's disease cases. In a similar fashion to non-human mammalian species, pyramidal neurons in the CA1 region showed a very low degree of neurofilament triplet immunoreactivity in the three younger control cases examined. However, in the other control cases of 49 years of age and older, many CA1 pyramidal neurons showed elevated neurofilament immunoreactivity. In the Alzheimer's disease cases, most of the surviving CA1 neurons showed intense labeling for the neurofilament triplet proteins, with many of these neurons giving off abnormal “sprouting” processes. Double labeling demonstrated that many of these neurons contained tangle-like or granular material that was immunoreactive for abnormal forms of tau and stained with thioflavine S, indicating that these neurons are in a transitional degenerative stage. An antibody to phosphorylated neurofilament proteins labeled a subset of neurofibrillary tangles in the Alzheimer's disease cases. However, following formic acid pre-treatment, the number of neurofibrillary tangles showing phosphorylated neurofilament protein immunoreactivity increased, with double labeling confirming that all of the tau-immunoreactive neurofibrillary tangles were also immunoreactive for phosphorylated neurofilament proteins. Immunoblotting demonstrated that there was a proportionately greater amount of the neurofilament triplet subunit proteins in hippocampal tissue from Alzheimer's disease cases as compared to controls. These results indicate that there are changes in the cytoskeleton of CA1 neurons associated with age which are likely to involve an increase in the level of neurofilament proteins and may be a predisposing factor contributing towards their high degree of vulnerability in degenerative conditions such as Alzheimer's disease. The cellular factors affecting hippocampal neurons during aging may be potentiated in Alzheimer's disease to result in even higher levels of intracellular neurofilament proteins and the progressive alterations of neurofilaments and other cytoskeletal proteins that finally results in neurofibrillary tangle formation and cellular degeneration.